Drugs / Topical Zinc Oxide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04505670 Background | Aug 2020 → Jul 2023 | — | University of Maryland, Baltimore | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Topical Zinc Oxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04505670 ↗ |
| Route | Topical | “All patients will receive topical zinc oxide 20% topically three times a day” NCT04505670 ↗ |